PhaseRx PZRXQ Stock
PhaseRx Price Chart
PhaseRx PZRXQ Financial and Trading Overview
| PhaseRx stock price | 0.0002 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.0002 USD |
| Volume | 400 USD |
| Avg. Volume | 430 USD |
| Market Cap | 15.2K USD |
| Beta (5Y Monthly) | -0.362676 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.13 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PZRXQ Valuation Measures
| Enterprise Value | 185.17K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.014 |
Trading Information
PhaseRx Stock Price History
| Beta (5Y Monthly) | -0.362676 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0002 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001185 USD |
PZRXQ Share Statistics
| Avg. Volume (3 month) | 430 USD |
| Avg. Daily Volume (10-Days) | 50 USD |
| Shares Outstanding | 11.69M |
| Float | 5.08M |
| Short Ratio | 0.34 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | 168.63K |
| Short % of Float | 2.52% |
| Short % of Shares Outstanding | 1.44% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2016 |
| Most Recent Quarter (mrq) | September 30, 2017 |
| Next Fiscal Year End | December 31, 2017 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -64.20% |
| Return on Equity (ttm) | -228.16% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -12955000 USD |
| Net Income Avi to Common (ttm) | -13891000 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.26M USD |
| Total Cash Per Share (mrq) | 0.45 USD |
| Total Debt (mrq) | 5.44M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.137 |
| Book Value Per Share (mrq) | -0.026 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12821000 USD |
| Levered Free Cash Flow (ttm) | -7682125 USD |
Profile of PhaseRx
| Country | United States |
| State | WA |
| City | Seattle |
| Address | 410 West Harrison Street |
| ZIP | 98119 |
| Phone | 206 805 6300 |
| Website | N/A |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technology platform, which allows the synthesis of missing enzyme inside the cell. Its therapeutic urea cycle disorder programs under development include PRX-OTC to treat ornithine transcarbamylase deficiency; PRX-ASL to treat argininosuccinate lyase deficiency; and PRX-ASS1 to treat argininosuccinate synthetase deficiency. The company was incorporated in 2006 and is headquartered in Seattle, Washington.
Q&A For PhaseRx Stock
What is a current PZRXQ stock price?
PhaseRx PZRXQ stock price today per share is 0.0002 USD.
How to purchase PhaseRx stock?
You can buy PZRXQ shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PhaseRx?
The stock symbol or ticker of PhaseRx is PZRXQ.
Which industry does the PhaseRx company belong to?
The PhaseRx industry is Biotechnology.
How many shares does PhaseRx have in circulation?
The max supply of PhaseRx shares is 75.99M.
What is PhaseRx Price to Earnings Ratio (PE Ratio)?
PhaseRx PE Ratio is now.
What was PhaseRx earnings per share over the trailing 12 months (TTM)?
PhaseRx EPS is -0.13 USD over the trailing 12 months.
Which sector does the PhaseRx company belong to?
The PhaseRx sector is Healthcare.